Chemistry:Iopromide
From HandWiki
Short description: Chemical compound
| Clinical data | |
|---|---|
| Trade names | Ultravist |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| Pregnancy category |
|
| Routes of administration | Intravascular |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | ~1% |
| Metabolism | None |
| Elimination half-life | 2 hours |
| Excretion | Kidneys |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H24I3N3O8 |
| Molar mass | 791.11187 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Iopromide is an iodinated contrast medium for X-ray imaging. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use; i.e., it is injected into blood vessels.[1]
It is commonly used in radiographic studies such as intravenous urograms, brain computer tomography (CT)[1] and CT pulmonary angiograms (CTPAs).
Medical uses
The radiocontrast agent is given intravenously in computed tomography (CT) scans, angiography and excretory urography.[2]
References
- ↑ 1.0 1.1 (in German) Austria-Codex. Vienna: Österreichischer Apothekerverlag. 2020. Ultravist 300 mg J/ml-Infusionsflaschen.
- ↑ "Prescribing information - Ultravist". Bayer Healthcare pharmaceuticals. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021425s028lbl.pdf.
External links
